Christian Waage bought HRTX
January 30, 2025 · Form 4 insider transaction
Christian Waage bought 17,950 shares of Heron Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,950
Price
$0.00
Total value
N/A
InsiderChristian Waage
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2025
Filing dateFebruary 3, 2025
Shares owned after84,130
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were granted as restricted stock units which vest in full on January 30, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock.